These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 9767358)

  • 1. Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activation.
    Selvais PL; Donckier JE; Robert A; Laloux O; van Linden F; Ahn S; Ketelslegers JM; Rousseau MF
    Eur J Clin Invest; 1998 Aug; 28(8):636-42. PubMed ID: 9767358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure.
    Selvais PL; Robert A; Ahn S; van Linden F; Ketelslegers JM; Pouleur H; Rousseau MF
    J Card Fail; 2000 Sep; 6(3):201-7. PubMed ID: 10997745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failure.
    Lee SC; Stevens TL; Sandberg SM; Heublein DM; Nelson SM; Jougasaki M; Redfield MM; Burnett JC
    J Card Fail; 2002 Jun; 8(3):149-54. PubMed ID: 12140807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenomedullin, endothelin, neuropeptide Y, atrial, brain, and C-natriuretic prohormone peptides compared as early heart failure indicators.
    Daggubati S; Parks JR; Overton RM; Cintron G; Schocken DD; Vesely DL
    Cardiovasc Res; 1997 Nov; 36(2):246-55. PubMed ID: 9463636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.
    Omland T; Aakvaag A; Bonarjee VV; Caidahl K; Lie RT; Nilsen DW; Sundsfjord JA; Dickstein K
    Circulation; 1996 Jun; 93(11):1963-9. PubMed ID: 8640969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac secretion of atrial and brain natriuretic peptides in acute ischaemic heart failure in pigs: effect of angiotensin II receptor antagonism.
    Klinge R; Djøseland O; Karlberg BE; Hall C
    Clin Physiol; 1997 Jul; 17(4):389-400. PubMed ID: 19361150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. The Christchurch Cardioendocrine Research Group.
    Richards AM; Nicholls MG; Yandle TG; Ikram H; Espiner EA; Turner JG; Buttimore RC; Lainchbury JG; Elliott JM; Frampton C; Crozier IG; Smyth DW
    Heart; 1999 Feb; 81(2):114-20. PubMed ID: 9922344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure.
    Isnard R; Pousset F; Chafirovskaïa O; Carayon A; Hulot JS; Thomas D; Komajda M
    Am Heart J; 2003 Oct; 146(4):729-35. PubMed ID: 14564330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical correlates of elevated plasma natriuretic peptides and Big endothelin-1 in a population of ambulatory patients with heart failure. A substudy of the Italian Network on Congestive Heart Failure (IN-CHF) registry. IN-CHF Investigators.
    Masson S; Gorini M; Salio M; Lucci D; Latini R; Maggioni AP
    Ital Heart J; 2000 Apr; 1(4):282-8. PubMed ID: 10824729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A direct comparison of the natriuretic peptides and their relationship to survival in chronic heart failure of a presumed non-ischaemic origin.
    Stanton E; Hansen M; Wijeysundera HC; Kupchak P; Hall C; Rouleau JL;
    Eur J Heart Fail; 2005 Jun; 7(4):557-65. PubMed ID: 15921795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BNP and ANP as diagnostic and predictive markers in heart failure with left ventricular systolic dysfunction.
    Falcão LM; Pinto F; Ravara L; van Zwieten PA
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):121-9. PubMed ID: 15526247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma N-terminal atrial natriuretic factor: a predictor of survival in patients with congestive heart failure.
    Dickstein K; Aarsland T; Hall C
    J Card Fail; 1997 Jun; 3(2):83-9. PubMed ID: 9220307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation.
    Wieczorek SJ; Wu AH; Christenson R; Krishnaswamy P; Gottlieb S; Rosano T; Hager D; Gardetto N; Chiu A; Bailly KR; Maisel A
    Am Heart J; 2002 Nov; 144(5):834-9. PubMed ID: 12422152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmented response in plasma brain natriuretic peptide to dynamic exercise in patients with left ventricular dysfunction and congestive heart failure.
    Kato M; Kinugawa T; Ogino K; Endo A; Osaki S; Igawa O; Hisatome I; Shigemasa C
    J Intern Med; 2000 Oct; 248(4):309-15. PubMed ID: 11086641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superiority of big endothelin-1 and endothelin-1 over natriuretic peptides in predicting survival in severe congestive heart failure: a 7-year follow-up study.
    Van Beneden R; Gurné O; Selvais PL; Ahn SA; Robert AR; Ketelslegers JM; Pouleur HG; Rousseau MF
    J Card Fail; 2004 Dec; 10(6):490-5. PubMed ID: 15599839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro)BNP.
    Rienstra M; Van Gelder IC; Van den Berg MP; Boomsma F; Van Veldhuisen DJ
    Europace; 2006 Jul; 8(7):482-7. PubMed ID: 16798760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma proatrial natriuretic factor is predictive of clinical status in patients with congestive heart failure.
    Dickstein K; Larsen AI; Bonarjee V; Thoresen M; Aarsland T; Hall C
    Am J Cardiol; 1995 Oct; 76(10):679-83. PubMed ID: 7572624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natriuretic peptides and the prevalence of congestive heart failure in patients with pacemakers.
    Gwechenberger M; Huelsmann M; Graf S; Berger R; Bonderman D; Stanek B; Rauscha F; Pacher R
    Eur J Clin Invest; 2004 Dec; 34(12):811-7. PubMed ID: 15606723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate.
    Loke I; Squire IB; Davies JE; Ng LL
    Eur J Heart Fail; 2003 Oct; 5(5):599-606. PubMed ID: 14607197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure.
    Berger R; Huelsman M; Strecker K; Bojic A; Moser P; Stanek B; Pacher R
    Circulation; 2002 May; 105(20):2392-7. PubMed ID: 12021226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.